Henan Asia-Pacific Institute of Osteopathy is located in Zhengzhou City, a famous city in the Central Plains. It is a provincial-level non-profit scientific research institution approved by the Science and Technology Department of Henan Province. It integrates scientific research, medical treatment, pharmacy, medical device research and development, technical training and achievement promotion. It is the advanced governing unit of the academic research institute of the National Orthopedic Hospital, the National Osteonecrosis Research and Treatment Center and the National Rheumatoid Immune Disease Treatment Center. The research institute has a large number of experts in orthopedics and osteopathy, and has a strong technical force to study osteoarthrosis. It undertakes a major task of national orthopedics and osteopathy research, and has affiliated Asia-Pacific Osteopathy Hospital and Zhengzhou Asia-Pacific Biotechnology Co., Ltd. Wang Rui, the dean and master of medicine, presided over the research topic of "repair activation therapy". After years of scientific research, based on the combination of traditional Chinese and western medicine, according to the biomechanical principle, the theory of self-balance adjustment of bone and joint biological pump was put forward, which opened up a new way to treat bone diseases. Authoritative appraisal by Shang Tianyu, Ma Zaishan, Professor Wang Fengyi and other osteopathy experts confirmed that this therapy was the first in China to reach the international advanced level and won the national scientific and technological achievements. Later, on the basis of this achievement, a more scientific and systematic treatment method was developed by using modern high-tech means, with remarkable curative effect, which was praised and praised by many patients at home and abroad.
Dean Wang Rui attaches great importance to the accumulation and summary of clinical achievements and experiences. He has personally written and published more than 3 papers, five of which have been included in large-scale anthologies such as A Mirror of High-tech Diagnosis and Treatment of Chinese Famous Doctors, China Classic Library, Selected Papers of National Modern Medical Science and Technology, and important international and domestic magazines, and have successively won prizes such as Henan Science and Technology Progress Award, International Science Award and Excellent Paper Award.
In p>25, the chief judge composed of four authoritative organizations, including China Academy of Traditional Chinese Medicine, China High-tech Intellectual Property Participation Selection Organizing Committee, China Balanced Medicine Research Association, and Hualian Cultural Development Center National Medical Network, awarded several awards to President Wang Rui, including:
"First Prize of the New Century Gold Cup of Chinese Famous Doctors";
"Gold Award for Leading High-tech Scientific Research Achievements of Chinese Famous Doctors";
"* * * and the gold medal for the contribution of Chinese famous medical experts".
In January p>25, he was specially appointed as a professor and researcher by British Medical College in Hong Kong.
In August p>25, he was specially appointed as an academician by Taiwan Province Zhongshan Academy of Medical Sciences.
In December p>25, he was co-elected as the vice chairman by world federation of traditional.
In July, 26, I was invited to attend the "China International Chinese Medicine Expo and International Chinese Medicine Orthopedics Forum" held in Beijing. He was awarded the title of "International Excellent Orthopedic Physician of Traditional Chinese Medicine."
President Wang Rui's arduous pioneering road and his achievements have been reported by Henan, CCTV and radio stations for more than 1 times, and his news has been reported by more than 3 newspapers and magazines nationwide for more than 6 times.
The name of Dean Wang Rui was also included in the Grand Ceremony of Chinese Famous Doctors and Experts.
Zhengzhou Asia-Pacific Biotechnology Co., Ltd. is a high-tech enterprise established in cooperation with Hong Kong Asia-Pacific Investment Group, mainly engaged in the research, development, production and sales of drugs and health products. Headquartered in Hongkong, R&D has more than a dozen doctoral and master's researchers and consultants in biology, medicine and chemistry, and maintains close relations with China Academy of Sciences and China Institute of Traditional Chinese Medicine. The production headquarters is located in Zhengzhou, a famous city in the Central Plains, and it is a production base for the technical cooperation between China and Hong Kong to produce pure natural biological products. At present, there are 78 employees, 35 management and technical employees, 26 marketing management cadres, a production plant with the most advanced equipment and facilities in modern management, three assembly lines of biopharmaceutical equipment imported from the United States, and fixed assets of 12 million yuan. It passed GMP certification in December 25 and ISO91 international quality certification in March 26. The company not only has first-class equipment, advanced biotechnology and excellent products, but also has a high-quality excellent management team with strategy, technology, understanding of the market and good management.
Zhengzhou Asia-Pacific Biotechnology Co., Ltd. has several advantages:
1. Excellent management team.
2. Have advanced market management concept and strategic vision.
3. It has advanced biotechnology support from Hong Kong, strong R&D capability and the latest international information.
4. Strong brand operation and market planning ability.
Zhengzhou Asia-Pacific Biotechnology Co., Ltd. has a great goal, and plans to develop into a famous high-tech enterprise of biological products and medical equipment in China within three years, with a famous brand in China and even in the international market, and make great contributions to the health and good life of all mankind.